Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone
Keyword(s):
Keyword(s):
2013 ◽
Vol 11
(5S)
◽
pp. 694-697
◽
Keyword(s):
Keyword(s):
2009 ◽
Vol 101
(7)
◽
pp. 1224-1224
◽
Keyword(s):
2016 ◽
Vol 12
(5)
◽
pp. 109
Keyword(s):